Preliminary in vitro angiographic comparison of the flow diversion behavior of Evolve and Pipeline devices.

The Evolve device demonstrated greater in vitro flow diversion effects than Pipeline. Comparative efficacy of the devices will need to be adjudicated based on clinical outcomes.